MDG1:FRA
MediGene AG
0,017 €
arrow_upward
+3,61%(+0,00060) 1D
30 ივნ, 22:00:00 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
News stories
From web sources and news partners
StreetInsider
·
8 წუთის წინ
Scinai signs $5.1M CDMO deal with Nasdaq-listed biopharma
CNBC
·
22 წუთის წინ
S&P 500 futures are mixed ahead of bank earnings
FinancialContent
·
51 წუთის წინ
Domino's (NASDAQ:DPZ) Surprises With Q3 2026 Sales
Profile
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia